Learn more about TD2’s comprehensive immuno-oncology research platform

TD2 offers a comprehensive panel of human and murine tumor models for adoptive cell therapy and immuno-oncology drug development.

CONTACT US

Have questions about how TD2 can assist with your regulatory needs? Reach out to our expert staff today to get started.